Literature DB >> 23787216

Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction.

Chin Meng Khoo1, Michael J Muehlbauer, Robert D Stevens, Zehra Pamuklar, Jiegen Chen, Christopher B Newgard, Alfonso Torquati.   

Abstract

BACKGROUND: Roux-en-Y gastric bypass (RYGB) surgery results in exaggerated postprandial insulin and incretin responses and increased susceptibility to hypoglycemia.
OBJECTIVE: We examined whether these features are due to caloric restriction (CR) or altered nutrient handling.
METHODS: We performed comprehensive analysis of postprandial metabolite responses during a 2-hour mixed-meal tolerance (MMT) test in 20 morbidly obese subjects with type 2 diabetes who underwent RYGB surgery or matched CR. Acylcarnitines and amino acids (AAs) were measured using targeted mass spectrometry. A linear mixed model was used to determine the main effect of interventions and interaction term to assess the effect of interventions on postprandial kinetics.
RESULTS: Two weeks after these interventions, several gut hormones (insulin, glucose-dependent insulinotropic polypeptide, and glucagon-like peptide 1), glucose, and multiple AAs, including branched-chain and aromatic species, exhibited a more rapid rate of appearance and clearance in RYGB surgery subjects than in CR subjects during the MMT test. In the RYGB surgery group, changes in leucine/isoleucine, methionine, phenylalanine, and glucagon-like peptide 1 response were associated with changes in insulin response. Levels of alanine, pyruvate, and lactate decreased significantly at the later stages of meal challenge in RYGB surgery subjects but increased with CR.
CONCLUSIONS: RYGB surgery results in improved metabolic flexibility (ie, greater disposal of glucose and AAs and more complete β-oxidation of fatty acids) compared with CR. The changes in the AA kinetics may augment the hormonal responses seen after RYGB surgery. The reduction in key gluconeogenic substrates in the postprandial state may contribute to increased susceptibility to hypoglycemic symptoms in RYGB surgery subjects.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23787216      PMCID: PMC3901799          DOI: 10.1097/SLA.0b013e318296633f

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  Direct assays of lactate, pyruvate, beta-hydroxybutyrate, and acetoacetate with a centrifugal analyzer.

Authors:  J L Hansen; E F Freier
Journal:  Clin Chem       Date:  1978-03       Impact factor: 8.327

2.  Stimulation of insulin secretion by amino acids.

Authors:  J C Floyd; S S Fajans; J W Conn; R F Knopf; J Rull
Journal:  J Clin Invest       Date:  1966-09       Impact factor: 14.808

3.  Noninsulinoma pancreatogenous hypoglycemia syndrome: an update in 10 surgically treated patients.

Authors:  G B Thompson; F J Service; J C Andrews; R V Lloyd; N Natt; J A van Heerden; C S Grant
Journal:  Surgery       Date:  2000-12       Impact factor: 3.982

Review 4.  Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.

Authors:  Andrew A Gumbs; Irvin M Modlin; Garth H Ballantyne
Journal:  Obes Surg       Date:  2005-04       Impact factor: 4.129

5.  Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.

Authors:  C Herrmann; R Göke; G Richter; H C Fehmann; R Arnold; B Göke
Journal:  Digestion       Date:  1995       Impact factor: 3.216

6.  Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal.

Authors:  A B Goldfine; E C Mun; E Devine; R Bernier; M Baz-Hecht; D B Jones; B E Schneider; J J Holst; M E Patti
Journal:  J Clin Endocrinol Metab       Date:  2007-09-25       Impact factor: 5.958

7.  Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.

Authors:  P Fieseler; S Bridenbaugh; R Nustede; J Martell; C Orskov; J J Holst; M A Nauck
Journal:  Am J Physiol       Date:  1995-05

8.  Peptones stimulate both the secretion of the incretin hormone glucagon-like peptide 1 and the transcription of the proglucagon gene.

Authors:  M Cordier-Bussat; C Bernard; F Levenez; N Klages; B Laser-Ritz; J Philippe; J A Chayvialle; J C Cuber
Journal:  Diabetes       Date:  1998-07       Impact factor: 9.461

9.  Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

Authors:  Rosa Morínigo; Violeta Moizé; Melina Musri; Antonio M Lacy; Salvador Navarro; José Luís Marín; Salvadora Delgado; Roser Casamitjana; Josep Vidal
Journal:  J Clin Endocrinol Metab       Date:  2006-02-14       Impact factor: 5.958

10.  Caloric restriction alters the metabolic response to a mixed-meal: results from a randomized, controlled trial.

Authors:  Kim M Huffman; Leanne M Redman; Lawrence R Landerman; Carl F Pieper; Robert D Stevens; Michael J Muehlbauer; Brett R Wenner; James R Bain; Virginia B Kraus; Christopher B Newgard; Eric Ravussin; William E Kraus
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

View more
  20 in total

1.  Comprehensive Assessment of the Effects of Sleeve Gastrectomy on Glucose, Lipid, and Amino Acid Metabolism in Asian Individuals with Morbid Obesity.

Authors:  Jie Yao; Jean-Paul Kovalik; Oi Fah Lai; Phong Ching Lee; Alvin Eng; Weng Hoong Chan; Kwang Wei Tham; Eugene Lim; Yong Mong Bee; Hong Chang Tan
Journal:  Obes Surg       Date:  2019-01       Impact factor: 4.129

Review 2.  Development of minimally invasive techniques for management of medically-complicated obesity.

Authors:  Farzin Rashti; Ekta Gupta; Suzan Ebrahimi; Timothy R Shope; Timothy R Koch; Christopher J Gostout
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  Reply to letter to the editor by dr. Dimitrios tsamis.

Authors:  Olga Bradnova
Journal:  Obes Surg       Date:  2014-08       Impact factor: 4.129

Review 4.  Metabolomics in Bariatric Surgery: Towards Identification of Mechanisms and Biomarkers of Metabolic Outcomes.

Authors:  Jane Ha; Yeongkeun Kwon; Sungsoo Park
Journal:  Obes Surg       Date:  2021-07-27       Impact factor: 4.129

5.  The Effects of Sleeve Gastrectomy and Gastric Bypass on Branched-Chain Amino Acid Metabolism 1 Year After Bariatric Surgery.

Authors:  Hong Chang Tan; Chin Meng Khoo; Matthew Zhen-Wei Tan; Jean-Paul Kovalik; Alvin Choong Meng Ng; Alvin Kim Hock Eng; Oi Fah Lai; Jian Hong Ching; Kwang Wei Tham; Shanker Pasupathy
Journal:  Obes Surg       Date:  2016-08       Impact factor: 4.129

Review 6.  Contribution of Malabsorption to Weight Loss After Roux-en-Y Gastric Bypass: a Systematic Review.

Authors:  Kamal K Mahawar; Alistair J Sharples
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

7.  The Effects of Bariatric Surgery on Islet Function, Insulin Secretion, and Glucose Control.

Authors:  Jonathan D Douros; Jenny Tong; David A D'Alessio
Journal:  Endocr Rev       Date:  2019-10-01       Impact factor: 19.871

Review 8.  Physiologic Mechanisms of Type II Diabetes Mellitus Remission Following Bariatric Surgery: a Meta-analysis and Clinical Implications.

Authors:  Sarah M Russel; Valentina Valle; Giuditta Spagni; Sarah Hamilton; Takshaka Patel; Nurlan Abdukadyrov; Yushen Dong; Antonio Gangemi
Journal:  J Gastrointest Surg       Date:  2020-01-02       Impact factor: 3.452

9.  The characterization of metabolites alterations in white adipose tissue of diabetic GK Rats after ileal transposition surgery by an untargeted metabolomics approach.

Authors:  Xiaorui Lyu; Kemin Yan; Weijie Chen; Yujie Wang; Huijuan Zhu; Hui Pan; Guole Lin; Linjie Wang; Hongbo Yang; Fengying Gong
Journal:  Adipocyte       Date:  2021-12       Impact factor: 4.534

10.  Insulin-like growth factor 1 predicts post-load hypoglycemia following bariatric surgery: a prospective cohort study.

Authors:  Bianca K Itariu; Maximilian Zeyda; Gerhard Prager; Thomas M Stulnig
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.